
Kimberly-Clark's $40 Billion Gamble on Kenvue Amid Controversy
In a bold move, Kimberly-Clark is set to acquire Kenvue for $40 billion, navigating turbulent waters following the Tylenol controversy. This merger unites iconic brands under one roof, positioning Kimberly-Clark for significant growth and public scrutiny alike.
Read full article



























